The UK Government published last week the long-awaited response to the consultation on proposals to improve the UK clinical trials legislation, with a foreword by life science champions Sir John Bell and Sir Jon Symonds. These reforms represent the biggest overhaul in UK clinical trials regulation in over 20 years and will make the UK one of the best countries to conduct clinical research for the benefit of patients and the life sciences sector. Continue reading for details on upcoming events, UK Parliament scrutiny of SVB Collapse, and more.
Meet Danny Bosch, Associate Director of Business Development and Commercial at Imperial College Health Partners (ICHP). In his blog, Danny details how ICHP are working towards creating healthier populations, by unlocking the potential of innovation and supporting NHS and industry.
XR Therapeutics is a start-up company, spun out of Newcastle University, helping people to overcome their phobias or anxiety using Virtual Reality technology. We spoke with Penny Day, Head of Operations, about the role of virtual reality in mental health treatment, and how XR is making waves in this space.
The Budget last week had major wins for BIA members including changes to R&D tax credits rates for loss-making SMEs. Read our press release and Martin’s analysis blog. This is a major, major win for a BIA campaign and wouldn’t have happened without member engagement and perseverance. Many thanks to all who helped – this non dilutive government co-investment will make all the difference as you crowd in private sector investment.
Worldwide drug discovery collaboration agreement with Ono to develop new antibody drugs against a novel macrophage target of interest in immuno-oncology
The Oxford, UK headquartered company, long established as a market leader in Europe and a pioneer in the development of innovative stroke AI solutions, is now poised to take its transformative technology to US stroke centers
The importance of building a thriving, diverse workplace is a widely recognised priority across all industries. The first of its kind sector data analysis by the BioIndustry Association (BIA) demonstrates strong inclusivity and an overall level of diversity in talent working within the UK innovative life sciences and biotech sector. The new state of the nation report, Diversity and Inclusion in UK Biotech, also reveals significant diversity gaps across disciplines, management levels and demographic traits which require action at both a company and sector level.
The UK’s Chancellor, Jeremy Hunt, has announced a special higher R&D tax relief rate for the UK’s most innovative businesses in his Spring Budget today (15 March). The UK’s trade association for innovative life sciences and biotech, the UK BioIndustry Association (BIA), has warmly welcomed the announcement.
Steve Bates OBE, CEO of the BIA, said on the sale of the Silicon Valley Bank UK to HSBC announced by the Bank of England, in consultation with the Prudential Regulation Authority (PRA), HM Treasury (HMT) and the Financial Conduct Authority (FCA).
As global macroeconomic uncertainty hit fundraising across all sectors, investment in UK biotech fell from the all-time highs seen in 2021, new analysis from the UK BioIndustry Association (BIA) and data and insights company Clarivate shows. However, global pharma and investors looked to UK innovation to strengthen their product pipelines, with UK biotechs being acquired at a premium and others achieving pivotal milestones in their development.
The BioIndustry Association (BIA) is the voice of the innovative life sciences and biotech industry, enabling and connecting the UK ecosystem so that businesses can start, grow and deliver world-changing innovation.
Explore opportunities to influence, connect and save with the BIA.
Influence
Connect
Save
policymakers, ensuring your voice is heard on the matters that are critical to the success of your organisation
with the UK ecosystem
through industry-leading events, expert committees and overseas missions
money with the BIA Business Solutions purchasing programme, helping you start, grow and deliver world-changing innovation